AroCell AB Cash Flow-to-Debt Ratio
AroCell AB cash flow-to-debt ratio. AroCell AB (AROC) has a Cash Flow-to-Debt Ratio of -0.08x as of March 2025, meaning its operating cash flow of Skr-1.11 Million could theoretically repay 0% of its total liabilities (Skr14.01 Million) in one year. See AroCell AB (AROC) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of AroCell AB (2011–2024)
Cash flow-to-debt ratio of AroCell AB from 2011 to 2024. Historical debt coverage capacity for AroCell AB across 11 annual periods. Check cash flow reinvestment rate of AroCell AB to assess the company's total reinvestment commitment from operating cash flow.
AroCell AB Cash Flow-to-Debt Ratio by Year (2011–2024)
AroCell AB cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for AroCell AB. For the full cash flow conversion analysis, see AroCell AB cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.18x | Skr-2.36 Million | Skr12.93 Million | ▲ +84.7% |
| 2023 | -1.19x | Skr-13.44 Million | Skr11.25 Million | ▼ -16.2% |
| 2022 | -1.03x | Skr-13.69 Million | Skr13.32 Million | ▲ +63.7% |
| 2021 | -2.83x | Skr-28.21 Million | Skr9.96 Million | ▲ +36.8% |
| 2020 | -4.48x | Skr-18.90 Million | Skr4.22 Million | ▼ -226.6% |
| 2019 | -1.37x | Skr-15.06 Million | Skr10.97 Million | ▲ +75.7% |
| 2018 | -5.65x | Skr-16.41 Million | Skr2.90 Million | ▼ -5.1% |
| 2017 | -5.37x | Skr-15.24 Million | Skr2.84 Million | ▼ -122.3% |
| 2016 | -2.42x | Skr-7.17 Million | Skr2.97 Million | ▲ +56.8% |
| 2015 | -5.59x | Skr-9.13 Million | Skr1.63 Million | ▼ -378.6% |
| 2011 | -1.17x | Skr-2.59 Million | Skr2.22 Million | — |